BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 38101777)

  • 1. [Interferon-α mediating the functional damage of CD56
    Zhao XG; Liu JQ; Huang HN; Lu ZM; Bai ZR; Li X; Qi JJ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 55(6):975-981. PubMed ID: 38101777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased oxidative stress contributes to impaired peripheral CD56
    Lu Z; Tian Y; Bai Z; Liu J; Zhang Y; Qi J; Jin M; Zhu J; Li X
    Arthritis Res Ther; 2022 Feb; 24(1):48. PubMed ID: 35172900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation status of CD56
    Liu M; Liu J; Zhang X; Xiao Y; Jiang G; Huang X
    Clin Rheumatol; 2021 Mar; 40(3):1103-1112. PubMed ID: 32797360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NK cells dysfunction in systemic lupus erythematosus: relation to disease activity.
    Henriques A; Teixeira L; Inês L; Carvalheiro T; Gonçalves A; Martinho A; Pais ML; da Silva JA; Paiva A
    Clin Rheumatol; 2013 Jun; 32(6):805-13. PubMed ID: 23377197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic Function and Cytokine Production of Natural Killer Cells and Natural Killer T-Like Cells in Systemic Lupus Erythematosis Regulation with Interleukin-15.
    Lin SJ; Kuo ML; Hsiao HS; Lee PT; Lee WI; Chen JY; Huang JL
    Mediators Inflamm; 2019; 2019():4236562. PubMed ID: 31049024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered Natural Killer Cell Subsets in Seropositive Arthralgia and Early Rheumatoid Arthritis Are Associated with Autoantibody Status.
    Chalan P; Bijzet J; Kroesen BJ; Boots AM; Brouwer E
    J Rheumatol; 2016 Jun; 43(6):1008-16. PubMed ID: 27036380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicolor flow cytometric analysis of TLR2 and TLR9 expression and function in NK cells from patients with ANCA-associated vasculitis.
    Scrivo R; Peruzzi G; Gattamelata A; Gross CC; Carletti R; Di Gioia C; Brandt J; Priori R; Morrone S; Santoni A; Valesini G
    Cytometry B Clin Cytom; 2018 May; 94(3):412-422. PubMed ID: 28834234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural Killer and Natural Killer T Cells in Juvenile Systemic Lupus Erythematosus: Relation to Disease Activity and Progression.
    Zahran AM; Abdel-Rahim MH; Elsayh KI; Hassanien MM; Mahran SA; Hetta HF
    Arch Immunol Ther Exp (Warsz); 2019 Jun; 67(3):161-169. PubMed ID: 30944972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human natural killer cell maturation defect supports in vivo CD56(bright) to CD56(dim) lineage development.
    Domaica CI; Fuertes MB; Uriarte I; Girart MV; Sardañons J; Comas DI; Di Giovanni D; Gaillard MI; Bezrodnik L; Zwirner NW
    PLoS One; 2012; 7(12):e51677. PubMed ID: 23240056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD56
    Vujanovic L; Chuckran C; Lin Y; Ding F; Sander CA; Santos PM; Lohr J; Mashadi-Hossein A; Warren S; White A; Huang A; Kirkwood JM; Butterfield LH
    Front Immunol; 2019; 10():14. PubMed ID: 30761123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic characterization of human CD8+ T cells with natural killer cell markers in comparison with natural killer cells and normal CD8+ T cells.
    Ohkawa T; Seki S; Dobashi H; Koike Y; Habu Y; Ami K; Hiraide H; Sekine I
    Immunology; 2001 Jul; 103(3):281-90. PubMed ID: 11454057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional molecular expression of nature killer cells correlated to HBsAg clearance in HBeAg-positive chronic hepatitis B patients during PEG-IFN α-2a therapy.
    Cao W; Lu H; Zhang L; Wang S; Deng W; Jiang T; Lin Y; Yang L; Bi X; Lu Y; Zhang L; Shen G; Liu R; Chang M; Wu S; Gao Y; Hao H; Xu M; Chen X; Hu L; Xie Y; Li M
    Front Immunol; 2022; 13():1067362. PubMed ID: 36479104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired natural killer cell responses are associated with loss of the highly activated NKG2A(+)CD57(+)CD56(dim) subset in HIV-1 subtype D infection in Uganda.
    Naluyima P; Eller MA; Laeyendecker O; Quinn TC; Serwadda D; Sewankambo NK; Gray RH; Michael NL; Wabwire-Mangen F; Robb ML; Sandberg JK
    AIDS; 2014 Jun; 28(9):1273-8. PubMed ID: 24959961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Favorable in vitro effects of combined IL-12 and IL-18 treatment on NK cell cytotoxicity and CD25 receptor expression in metastatic melanoma patients.
    Mirjačić Martinović K; Babović N; Džodić R; Jurišić V; Matković S; Konjević G
    J Transl Med; 2015 Apr; 13():120. PubMed ID: 25889680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A CD8α(-) subpopulation of macaque circulatory natural killer cells can mediate both antibody-dependent and antibody-independent cytotoxic activities.
    Vargas-Inchaustegui DA; Demberg T; Robert-Guroff M
    Immunology; 2011 Nov; 134(3):326-40. PubMed ID: 21978002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD56
    Wang H; Zeng Y; Zhang M; Ma H; Xu B; Jiang H; Wang J; Li G
    Hum Immunol; 2019 Oct; 80(10):871-877. PubMed ID: 31326139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expansion of functionally skewed CD56-negative NK cells in chronic hepatitis C virus infection: correlation with outcome of pegylated IFN-alpha and ribavirin treatment.
    Gonzalez VD; Falconer K; Björkström NK; Blom KG; Weiland O; Ljunggren HG; Alaeus A; Sandberg JK
    J Immunol; 2009 Nov; 183(10):6612-8. PubMed ID: 19846870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of Circulating Natural Killer Cells and Their Interferon-γ Production in Active Adult-onset Still Disease.
    Shimojima Y; Kishida D; Ueno KI; Ushiyama S; Ichikawa T; Sekijima Y
    J Rheumatol; 2019 Oct; 46(10):1268-1276. PubMed ID: 30770498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of IL-24 in NK cell activation and its clinical implication in systemic lupus erythematosus.
    Tang Y; Sun X; Wang Y; Luan H; Zhang R; Hu F; Sun X; Li X; Guo J
    Clin Rheumatol; 2021 Jul; 40(7):2707-2715. PubMed ID: 33534028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The phenotype of CD3-CD56
    Soelistyoningsih D; Susianti H; Kalim H; Handono K
    Reumatologia; 2022; 60(4):258-265. PubMed ID: 36186836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.